These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
575 related items for PubMed ID: 17130555
1. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Murawski MR, Litherland SA, Clare-Salzler MJ, Davoodi-Semiromi A. Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555 [Abstract] [Full Text] [Related]
2. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C. Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822 [Abstract] [Full Text] [Related]
3. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M, Piccirillo CA. J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [Abstract] [Full Text] [Related]
4. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM. J Immunol; 2011 Apr 15; 186(8):4862-71. PubMed ID: 21389253 [Abstract] [Full Text] [Related]
5. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M. Exp Hematol; 2008 Feb 15; 36(2):181-92. PubMed ID: 18023521 [Abstract] [Full Text] [Related]
7. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice. Xia J, Liu W, Hu B, Tian Z, Yang Y. Clin Immunol; 2010 Feb 15; 134(2):130-9. PubMed ID: 19875339 [Abstract] [Full Text] [Related]
8. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, Sakaguchi S. Int Immunol; 2006 Aug 15; 18(8):1197-209. PubMed ID: 16772372 [Abstract] [Full Text] [Related]
9. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model. Wang S, Jiang J, Guan Q, Lan Z, Wang H, Nguan CY, Jevnikar AM, Du C. Transpl Immunol; 2008 May 15; 19(2):93-102. PubMed ID: 18503884 [Abstract] [Full Text] [Related]
10. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y. Transpl Immunol; 2007 Apr 15; 17(3):153-61. PubMed ID: 17331841 [Abstract] [Full Text] [Related]
11. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, Bloquet S, Tanchot C, Bourgeois C. Eur J Immunol; 2010 Sep 15; 40(9):2528-38. PubMed ID: 20690182 [Abstract] [Full Text] [Related]
12. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation. Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B, Bommhardt UH. J Immunol; 2009 Nov 15; 183(10):6124-34. PubMed ID: 19841181 [Abstract] [Full Text] [Related]
13. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T. Eur J Immunol; 2008 May 15; 38(5):1381-90. PubMed ID: 18412171 [Abstract] [Full Text] [Related]
14. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Steinborn A, Haensch GM, Mahnke K, Schmitt E, Toermer A, Meuer S, Sohn C. Clin Immunol; 2008 Dec 15; 129(3):401-12. PubMed ID: 18805741 [Abstract] [Full Text] [Related]
16. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells. Crellin NK, Garcia RV, Levings MK. J Immunol Methods; 2007 Jul 31; 324(1-2):92-104. PubMed ID: 17582431 [Abstract] [Full Text] [Related]
17. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. Zhao L, Sun L, Wang H, Ma H, Liu G, Zhao Y. J Leukoc Biol; 2007 Jun 31; 81(6):1386-94. PubMed ID: 17369496 [Abstract] [Full Text] [Related]
18. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L. Proc Natl Acad Sci U S A; 2007 Apr 10; 104(15):6335-40. PubMed ID: 17389382 [Abstract] [Full Text] [Related]
19. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W. Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651 [Abstract] [Full Text] [Related]
20. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH. J Immunol; 2009 Dec 01; 183(11):7602-10. PubMed ID: 19917691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]